Published in PLoS One on September 11, 2012
Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B. Cell Res (2014) 0.97
FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R. J Transl Med (2015) 0.83
γ-Tocotrienol induces paraptosis-like cell death in human colon carcinoma SW620 cells. PLoS One (2013) 0.82
FH535 inhibited metastasis and growth of pancreatic cancer cells. Onco Targets Ther (2015) 0.81
DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration. PLoS One (2014) 0.78
WNT/β-Catenin signaling pathway regulates non-tumorigenesis of human embryonic stem cells co-cultured with human umbilical cord mesenchymal stem cells. Sci Rep (2017) 0.75
Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol (2009) 22.22
Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell (2009) 18.31
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest (2011) 14.22
Putting tumours in context. Nat Rev Cancer (2001) 12.37
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res (2009) 5.68
Collagen density promotes mammary tumor initiation and progression. BMC Med (2008) 5.13
ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol (2003) 4.24
The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol (1990) 3.82
Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell (2005) 3.67
Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer (2010) 2.94
Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res (2006) 2.86
Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense alpha 2 integrin mRNA in mammary cells. J Cell Sci (1995) 2.39
Endothelial cells use alpha 2 beta 1 integrin as a laminin receptor. J Cell Biol (1989) 2.31
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med (2011) 2.21
Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol (2010) 2.20
MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. EMBO J (2007) 2.16
Contractility of the cell rear drives invasion of breast tumor cells in 3D Matrigel. Proc Natl Acad Sci U S A (2011) 1.98
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. Mod Pathol (2010) 1.79
Targeting the tumor microenvironment. Front Biosci (2007) 1.72
WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res (2009) 1.70
Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat Cell Biol (1999) 1.65
Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast. Clin Cancer Res (2008) 1.58
Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name? Am J Pathol (1999) 1.54
NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res (2009) 1.53
The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer. J Cell Biochem (2012) 1.47
LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc Natl Acad Sci U S A (2010) 1.47
Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle. Cell Biochem Biophys (2007) 1.45
Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis. Development (2003) 1.42
A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities. Mol Cancer Ther (2008) 1.30
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer. J Natl Cancer Inst (2010) 1.26
β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis (2010) 1.20
Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and alpha 4 beta 1 integrin. Cancer Res (1995) 1.20
NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer. PLoS One (2011) 1.19
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms. J Cell Biol (2004) 1.18
Silymarin targets β-catenin signaling in blocking migration/invasion of human melanoma cells. PLoS One (2011) 1.16
Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A). Biochem J (2007) 1.16
CSPG4 in cancer: multiple roles. Curr Mol Med (2010) 1.15
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res (2011) 1.11
HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene (2011) 1.10
CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma. Pigment Cell Melanoma Res (2011) 1.09
Shining new light on 3D cell motility and the metastatic process. Trends Cell Biol (2009) 1.09
CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol Biol Cell (1996) 1.07
A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion. J Biol Chem (1998) 1.06
Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth. J Invest Dermatol (2004) 1.06
Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model. Breast Cancer Res Treat (2008) 1.04
Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma. Acta Neuropathol (2011) 1.03
Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition. Cancer Res (2009) 1.03
Functional and clinical relevance of chondroitin sulfate proteoglycan 4. Adv Cancer Res (2010) 1.01
Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen. J Biol Chem (2001) 0.97
Tyrosine phosphorylation of transcriptional coactivator WW-domain binding protein 2 regulates estrogen receptor α function in breast cancer via the Wnt pathway. FASEB J (2011) 0.94
Expression and clinical significance of NEDD9 in lung tissues. Med Oncol (2012) 0.92
β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast. Mod Pathol (2010) 0.89
Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion. Semin Cancer Biol (1996) 0.87
Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor. Br J Cancer (2011) 0.86
The genome sequence of the malaria mosquito Anopheles gambiae. Science (2002) 20.36
Genome assembly comparison identifies structural variants in the human genome. Nat Genet (2006) 6.93
Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse. PLoS Biol (2004) 4.08
Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse. Proc Natl Acad Sci U S A (2003) 3.93
Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet (2003) 3.55
Human chromosome 7: DNA sequence and biology. Science (2003) 3.02
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J Clin Oncol (2011) 2.78
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer. Cancer Discov (2012) 2.53
Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients. J Clin Oncol (2005) 2.43
Assessing semantic similarity measures for the characterization of human regulatory pathways. Bioinformatics (2006) 2.29
Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer (2006) 2.00
The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer. Ann Surg Oncol (2008) 1.87
Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol (2011) 1.85
BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenetic model. Hum Pathol (2013) 1.67
Genomic alterations associated with early stages of breast tumor metastasis. Ann Surg Oncol (2008) 1.61
Standard preanalytical coding for biospecimens: defining the sample PREanalytical code. Cancer Epidemiol Biomarkers Prev (2010) 1.60
Standard versus pH-adjusted and lidocaine supplemented radiocolloid for patients undergoing sentinel-lymph-node mapping and biopsy for early breast cancer (PASSION-P trial): a double-blind, randomised controlled trial. Lancet Oncol (2009) 1.57
Prospective trial of voice outcomes after thyroidectomy: evaluation of patient-reported and clinician-determined voice assessments in identifying postthyroidectomy dysphonia. Surgery (2008) 1.53
Biospecimen reporting for improved study quality (BRISQ). J Proteome Res (2011) 1.48
Correlation of levels and patterns of genomic instability with histological grading of DCIS. Ann Surg Oncol (2007) 1.47
The impact of recurrent laryngeal neuromonitoring on multi-dimensional voice outcomes following thyroid surgery. J Surg Oncol (2011) 1.46
Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway. Carcinogenesis (2009) 1.35
A gene expression signature that defines breast cancer metastases. Clin Exp Metastasis (2008) 1.34
Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep (2010) 1.32
High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics (2003) 1.27
Functional identity of genes detectable in expression profiling assays following globin mRNA reduction of peripheral blood samples. Clin Biochem (2007) 1.25
A prospective evaluation of patients undergoing surgery for the palliation of an advanced malignancy. Ann Surg Oncol (2002) 1.25
Efficiency analysis of competing tests for finding differentially expressed genes in lung adenocarcinoma. Cancer Inform (2008) 1.21
High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer. Cancer Epidemiol Biomarkers Prev (2003) 1.20
Totally transumbilical endoscopic cholecystectomy without visible abdominal scar using improved instruments. Surg Endosc (2008) 1.17
Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling. Nat Med (2013) 1.15
Effect of ASCO/CAP guidelines for determining ER status on molecular subtype. Ann Surg Oncol (2012) 1.14
Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women. Cancer (2011) 1.14
Development of a Bayesian classifier for breast cancer risk stratification: a feasibility study. Eplasty (2010) 1.14
TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression. Clin Exp Metastasis (2008) 1.14
Biospecimen Reporting for Improved Study Quality. Biopreserv Biobank (2011) 1.12
Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients. J Lipid Res (2007) 1.11
Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas. Oncogene (2002) 1.11
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. Breast Cancer Res (2011) 1.10
Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma. J Mol Med (Berl) (2007) 1.08
[Establishment and comparative genomic hybridization analysis of human esophageal carcinomas cell line EC9706]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2002) 1.08
Outer breast quadrants demonstrate increased levels of genomic instability. Ann Surg Oncol (2004) 1.08
Transumbilical endoscopic surgery: a preliminary clinical report. Surg Endosc (2008) 1.07
Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev (2009) 1.06
Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides. Breast Cancer Res Treat (2005) 1.06
The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. Thyroid (2006) 1.06
Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC). Biopreserv Biobank (2012) 1.05
Proteomics of breast carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.04
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer. Ann Surg Oncol (2006) 1.03
Breast cancer in the personal genomics era. Curr Genomics (2010) 1.02
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology. Oncol Rep (2007) 1.02
Electrical impedance scanning for the early detection of breast cancer in young women: preliminary results of a multicenter prospective clinical trial. J Clin Oncol (2005) 1.00
Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg (2005) 1.00
Lung cancer survival among black and white patients in an equal access health system. Cancer Epidemiol Biomarkers Prev (2012) 0.99
DW4TR: A Data Warehouse for Translational Research. J Biomed Inform (2011) 0.99
HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver. J Lipid Res (2010) 0.99
Performance of whole-genome amplified DNA isolated from serum and plasma on high-density single nucleotide polymorphism arrays. J Mol Diagn (2008) 0.98
Genomic instability in histologically normal breast tissues: implications for carcinogenesis. Lancet Oncol (2004) 0.98
Profiling tumor-associated autoantibodies for the detection of colon cancer. Clin Cancer Res (2008) 0.98
Detecting outlier microarray arrays by correlation and percentage of outliers spots. Cancer Inform (2007) 0.98
Derlin-1 is overexpressed on the tumor cell surface and enables antibody-mediated tumor targeting therapy. Clin Cancer Res (2008) 0.97
Expression of MRP14 gene is frequently down-regulated in Chinese human esophageal cancer. Cell Res (2004) 0.97
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes. Breast Cancer Res (2012) 0.96
The effects of stride length and stride frequency on trunk coordination in human walking. Gait Posture (2010) 0.96
A novel role for tissue factor pathway inhibitor-2 in the therapy of human esophageal carcinoma. Hum Gene Ther (2009) 0.96
Clinical features of multiple primary malignancies: a retrospective analysis of 72 Chinese patients. Asian Pac J Cancer Prev (2014) 0.96
The evaluation of casualties from Operation Iraqi Freedom on return to the continental United States from March to June 2003. J Am Coll Surg (2005) 0.95
Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group. J Mol Diagn (2012) 0.95
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients. Clin Cancer Res (2006) 0.95
Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett (2006) 0.93
Prospective study of electrical impedance scanning for identifying young women at risk for breast cancer. Breast Cancer Res Treat (2006) 0.93
HYOU1/Orp150 expression in breast cancer. Med Sci Monit (2007) 0.93
Quadruple primary malignancy patient with survival time more than 20 years. World J Gastroenterol (2013) 0.93
Socioeconomic disparities and breast cancer hormone receptor status. Cancer Causes Control (2012) 0.92
Race and colon cancer survival in an equal-access health care system. Cancer Epidemiol Biomarkers Prev (2013) 0.92
P-cadherin promotes liver metastasis and is associated with poor prognosis in colon cancer. Am J Pathol (2011) 0.91
Intensive cardiovascular risk reduction induces sustainable changes in expression of genes and pathways important to vascular function. Circ Cardiovasc Genet (2014) 0.91
Autologous pancreatic islet transplantation for severe trauma. N Engl J Med (2010) 0.90
The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response. Clin Vaccine Immunol (2011) 0.90
Does breast tumor heterogeneity necessitate further immunohistochemical staining on surgical specimens? J Am Coll Surg (2012) 0.89
Amplification of HER2 is a marker for global genomic instability. BMC Cancer (2008) 0.88
Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas. Breast Cancer Res Treat (2004) 0.88
Electrical impedance scanning as a new breast cancer risk stratification tool for young women. J Surg Oncol (2008) 0.88
Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization. Cancer Genet Cytogenet (2004) 0.88